SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-013945
Filing Date
2023-05-11
Accepted
2023-05-11 16:10:50
Documents
96
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nby20230331_10q.htm   iXBRL 10-Q 1353167
2 EXHIBIT 31.1 ex_512611.htm EX-31.1 8170
3 EXHIBIT 31.2 ex_512612.htm EX-31.2 8476
4 EXHIBIT 32.1 ex_512613.htm EX-32.1 4147
5 EXHIBIT 32.2 ex_512614.htm EX-32.2 4192
  Complete submission text file 0001437749-23-013945.txt   8639470

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA nby-20230331.xsd EX-101.SCH 94399
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nby-20230331_cal.xml EX-101.CAL 45052
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20230331_def.xml EX-101.DEF 590223
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20230331_lab.xml EX-101.LAB 464301
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20230331_pre.xml EX-101.PRE 622862
90 EXTRACTED XBRL INSTANCE DOCUMENT nby20230331_10q_htm.xml XML 1565037
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33678 | Film No.: 23911100
SIC: 2834 Pharmaceutical Preparations